Global Organ and Tissue Transplantation and Alternative Market Growth 2024-2031

As the global economy mends, the 2021 growth of Organ and Tissue Transplantation and Alternative will have significant change from previous year. According to our (LP Information) latest study, the global Organ and Tissue Transplantation and Alternative market size is USD million in 2022 from USD 95740 million in 2021, with a change of % between 2021 and 2022. The global Organ and Tissue Transplantation and Alternative market size will reach USD 150970 million in 2028, growing at a CAGR of 6.7% over the analysis period.
The United States Organ and Tissue Transplantation and Alternative market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Organ and Tissue Transplantation and Alternative market, reaching US$ million by the year 2028. As for the Europe Organ and Tissue Transplantation and Alternative landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Organ and Tissue Transplantation and Alternative players cover Abbott, Arthrex, Biomet, and Bristol-Myers, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Organ and Tissue Transplantation and Alternative market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Organ Transplantation
Tissue Transplantation
Cell Transplantation
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospital
Clinic
Laboratory
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Abbott
Arthrex
Biomet
Bristol-Myers
Centacor
CryoLife, Inc.
Dr. Franz Köhler Chemie GmbH
Novartis
Organ Transport Systems
Organogenesis, Inc.
XVIVO Perfusion AB